Uncertainty Intervention for Anxiety
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a single session can alter reactions to uncertainty and ambiguity. It focuses on whether this intervention affects decision-making and brain responses in unclear situations. Participants will engage in one of two digital, self-guided sessions: one teaches strategies for managing uncertainty (uncertainty-focused single session intervention), while the other emphasizes maintaining a healthy lifestyle (maintaining a healthy lifestyle single session intervention). Individuals who frequently struggle with uncertainty and can read and write in English may be well-suited for this study. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance coping strategies for uncertainty.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that single-session treatments focused on dealing with uncertainty are generally easy for people to handle. Studies have found that these treatments can lower emotional distress without causing major side effects. For example, one study found that participants did not report any serious negative reactions after completing the treatment. Additionally, similar single-session treatments have helped people feel better and more open to change. This suggests that the approach is safe and manageable for participants.12345
Why are researchers excited about this trial?
Unlike traditional treatments for anxiety that often involve medication or extensive therapy sessions, the uncertainty-focused single session intervention (SSI) is a digital, self-guided program that emphasizes embracing uncertainty. This approach leverages concepts like neuroplasticity to help individuals reshape their thoughts and behaviors, making it a novel psychological tool. Researchers are particularly excited because this intervention is concise, potentially offering rapid improvements in anxiety management without the need for prolonged therapy or medication, which could increase accessibility and reduce costs for patients.
What evidence suggests that this trial's interventions could be effective for anxiety?
Research has shown that single session interventions (SSIs) focused on dealing with uncertainty can help reduce anxiety. In this trial, participants may receive the Uncertainty-focused single session intervention, which teaches ways to better cope with uncertainty using concepts like the brain's ability to change and techniques that adjust thinking and behavior. One study found that about 58.3% of participants improved in managing uncertainty, increasing to 66% after three months. Although more research is needed, these interventions appear promising in helping people feel more at ease with uncertainty, potentially lowering anxiety symptoms.26789
Are You a Good Fit for This Trial?
This trial is for adults aged 25 to 60 who are right-handed, can read and write English, and have a discomfort with uncertainty. They must be able to consent and not have an IQ below 80 or significant neurological issues, pregnancy, electrical implants in the body, or a history of severe mental health conditions like psychosis or autism.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo a single session intervention to test changes in ambiguity aversion
Assessment
Participants complete decision making tasks and questionnaires before and after the intervention
Follow-up
Participants are monitored for changes in ambiguity aversion and hopelessness
What Are the Treatments Tested in This Trial?
Interventions
- Maintaining a healthy lifestyle single session intervention
- Uncertainty-focused single session intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator